TacticScaleWhat BWX Technologies Does & How It Makes Money (BWXT)
Updated October 2026 · reflects BWX Technologies's latest reported financials
U.S. maker of naval nuclear reactors, nuclear fuel and components. Most revenue comes from U.S.
How BWX Technologies makes money
Most revenue comes from U.S. government contracts for naval nuclear components, reactors, fuel and uranium down-blending, many of them sole-source. The rest comes from selling nuclear plant equipment, fuel, services and medical isotopes to commercial utilities and healthcare customers, mainly in the U.S. and Canada.
What BWX Technologies does
BWX Technologies (formerly The Babcock & Wilcox Company, renamed in 2015) is a nuclear manufacturer headquartered in Lynchburg, Virginia, with roots going back to 1867. Its Government Operations segment makes precision naval nuclear components, reactors and fuel, down-blends government uranium stockpiles, and supplies proprietary valves, fittings and defense components. It also makes research reactor fuel for universities and national laboratories. The Commercial Operations segment serves the civilian nuclear market in the U.S., Canada and elsewhere. It sells steam generators, pressure vessels, heat exchangers, fuel, fuel handling systems and containers for storing spent fuel and high-level nuclear waste. The segment also produces medical radioisotopes, radiopharmaceuticals and medical devices, and provides engineering, inspection, maintenance and lifecycle management services for nuclear power plants.
Products & services
- Naval nuclear reactors and components
- Nuclear fuel and research reactor fuel elements
- Uranium down-blending
- Commercial nuclear steam generators and pressure vessels
- Medical radioisotopes and radiopharmaceuticals
- Nuclear plant inspection, maintenance and lifecycle services
What is BWX Technologies worth?
On an owner-earnings DCF, BWX Technologies's most-likely value is about $110 versus a recent price near $144 (24% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$36) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Curtiss-Wright (CW) · Huntington Ingalls Industries (HII) · RTX (RTX) · SPX Technologies (SPXC) · WuXi Biologics (2269.HK)